Praktische Empfehlungen der Deutschen Diabetes Gesellschaft zum Diabetesmanagement bei Patientinnen und Patienten mit einer COVID-19-Erkrankung

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Stefan R. Bornstein - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
  • Baptist Gallwitz - , University Hospital Tübingen (Author)
  • Monika Kellerer - , Marienhospital Stuttgart (Author)
  • Barbara Ludwig - , Department of Internal Medicine III, University Hospital Carl Gustav Carus Dresden (Author)
  • Dirk Müller-Wieland - , RWTH Aachen University (Author)
  • Andreas Neu - , University Hospital Tübingen (Author)
  • Hans Martin Reuter - (Author)
  • Michael Roden - , University Hospital Duesseldorf (Author)
  • Jochen Seufert - , University Medical Center Freiburg (Author)

Abstract

In subjects with an infection with the novel corona virus SARS-CoV-2 and COVID-19 disease, diabetes mellitus and cardiovascular diseases are highly prevalent comorbidities. Diabetes patients with comorbidities and/or diabetes complications seem to have a higher risk for a severe course of the COVID-19 disease including the development of ARDS or multiorgan failure. The exact interrelations between diabetes and the individual clinical course of COVID-19 are not completely understood at this time. The German Diabetes Association (DDG) summarizes basic principle practice recommendations for the treatment of patients with diabetes and concomitant COVID-19 disease.

Translated title of the contribution
Practical recommendations of the German Diabetes Society for the management of diabetes in patients with COVID-19

Details

Original languageGerman
Pages (from-to)36-41
Number of pages6
JournalDiabetologe
Volume17
Issue number1
Publication statusPublished - Jan 2021
Peer-reviewedYes

Keywords

Sustainable Development Goals

Keywords

  • COVID 19 disease, Diabetes therapy, SARS CoV 2 infection, Type 1 diabetes, Type 2 diabetes